
    
      The objectives of this study are to evaluate the therapeutic equivalence and safety of
      Adapalene Gel 0.3% and DifferinÂ® (adapalene gel 0.3%) in the treatment of acne vulgaris and
      to demonstrate the superiority of the efficacy of the test and reference products over the
      placebo.
    
  